NBIX News
Neurocrine Biosciences, Inc.
$135.91
+$0.78(+0.58%)
53
Overall
70
Value
18
Tech
71
Quality
Market Cap
$13.82B
Volume
1.50M
52W Range
$122.14 - $186.12
Target Price
$206.03
NBIX news: the latest Neurocrine Biosciences, Inc. headlines, press releases and market updates, newest first.
Latest NBIX News
- RBC Capital Reaffirms Their Buy Rating on Neurocrine (NBIX)TipRanks Auto-Generated Intelligence Newsdesk · Oct 9, 2026
- Bernstein Remains a Buy on Neurocrine (NBIX)TipRanks Auto-Generated Intelligence Newsdesk · Sep 26, 2026
- Neurocrine (NBIX) Gets a Buy from RBC CapitalTipRanks Auto-Generated Intelligence Newsdesk · Sep 24, 2026
- Neurocrine (NBIX) Receives a Buy from CCB Intl.TipRanks Auto-Generated Intelligence Newsdesk · Sep 21, 2026
- Neurocrine (NBIX) Receives a Buy from RBC CapitalTipRanks Auto-Generated Intelligence Newsdesk · Sep 15, 2026
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | NBIX | $135.91 | +0.6% | 1.50M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Neurocrine Biosciences, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW